Showing results (91-100 of 145) with videos related to
Sort By:
Pageof 15
Biochimica Et Biophysica Acta|July 27, 2014
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropyJean-Rémy Marchand, Andrea Carotti, Daniela Passeri, et al.Chemmedchem|October 2, 2015
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 InhibitorsDaniela Passeri, Emidio Camaioni, Paride Liscio, et al.Journal of Chemical Information and Modeling|August 14, 2008
Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5Antonio Macchiarulo, Antimo Gioiello, Charles Thomas, et al.The Journal of Organic Chemistry|August 3, 2002
Spiro[2.2]pentane as a dissymmetric scaffold for conformationally constrained analogues of glutamic acid: focus on racemic 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acidsRoberto Pellicciari, Maura Marinozzi, Emidio Camaioni, et al.The Journal of Pharmacology and Experimental Therapeutics|April 30, 2005
A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosisStefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli, et al.Chemmedchem|April 15, 2008
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivativesRoberto Pellicciari, Emidio Camaioni, Gabriele Costantino, et al.Journal of Medicinal Chemistry|August 20, 2004
Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acidRoberto Pellicciari, Gabriele Costantino, Emidio Camaioni, et al.Journal of Medicinal Chemistry|January 19, 2018
α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) BiosynthesisRoberto Pellicciari, Paride Liscio, Nicola Giacchè, et al.Journal of Medicinal Chemistry|March 1, 2008
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studiesHiroyuki Sato, Antonio Macchiarulo, Charles Thomas, et al.Journal of Medicinal Chemistry|August 9, 2002
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activityRoberto Pellicciari, Stefano Fiorucci, Emidio Camaioni, et al.Pageof 15